-
Mashup Score: 21
Bishal Gyawali, MD, PhD, breaks down the 15 most common misunderstandings about the use of surrogate endpoints in oncology.
Source: www.oncologynewscentral.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 10Reading Clinical Research Abstracts: When, Why, and How? - 24 day(s) ago
Dr Bishal Gyawali discusses tips for when to read abstracts of a clinical trial publication.
Source: www.medscape.comCategories: General Medicine News, Hem/OncsTweet-
New video now live on the Critical Appraisal Skills Lab series @Medscape @MedscapeOnc. When do I read the abstract of an article? Why do I read the abstract? How do I read the abstract? https://t.co/KHF69seVMA https://t.co/P8kIXmqbIC
-
-
Mashup Score: 10Reading Clinical Research Abstracts: When, Why, and How? - 25 day(s) ago
Dr Bishal Gyawali discusses tips for when to read abstracts of a clinical trial publication.
Source: www.medscape.comCategories: General Medicine News, Hem/OncsTweet-
New video now live on the Critical Appraisal Skills Lab series @Medscape @MedscapeOnc. When do I read the abstract of an article? Why do I read the abstract? How do I read the abstract? https://t.co/KHF69seVMA https://t.co/P8kIXmqbIC
-
-
Mashup Score: 10Reading Clinical Research Abstracts: When, Why, and How? - 26 day(s) ago
Dr Bishal Gyawali discusses tips for when to read abstracts of a clinical trial publication.
Source: www.medscape.comCategories: General Medicine News, Hem/OncsTweet-
New video now live on the Critical Appraisal Skills Lab series @Medscape @MedscapeOnc. When do I read the abstract of an article? Why do I read the abstract? How do I read the abstract? https://t.co/KHF69seVMA https://t.co/P8kIXmqbIC
-
-
Mashup Score: 1GOIS: ASCO- GOIS International Webinars (ASCO-GOIS IW) Series - 2 month(s) ago
by Site Admin – Wednesday, 18 September 2024, 1:31 AM 2 nd Webinar โ Notions and needs for Global Oncology-Implementing Science to increase affordability of better value global cancer care. October 9, 2024 at 3.00pm-5.00pm GMT GOIS: Global Oncology-Implementing Science Program , Global Oncology University ( GO-U) The ASCO- GOIS International webinars (ASCO- GOIS IW): This series will continue the brainstorming reviewing and the discussion started in the Global Oncology-Implementing Science (GOIS) program
Source: icedoc.websiteCategories: General Medicine News, Hem/OncsTweet-
Register Today for the Free ASCO-GOIS Webinar on Global Oncology on October 9. https://t.co/g9IAez7d2p
-
-
Mashup Score: 61st IACAPAP Regional Webinar (Asia Region) - Dr Soumitra Datta - 2 month(s) ago
๐ฉ๐๐๐ ๐๐ ๐๐ ๐๐๐พ ๐ญ๐๐ ๐๐๐๐๐ฃ๐๐ฃ ๐ฅ๐ฒ๐ด๐ถ๐ผ๐ป๐ฎ๐น ๐ช๐ฒ๐ฏ๐ถ๐ป๐ฎ๐ฟ, ๐บ๐๐ฝ ๐ ๐๐๐๐พ๐ ๐๐ ๐๐๐พ ๐๐๐๐๐ผ โ๐ฃ๐ฎ๐ฒ๐ฑ๐ถ๐ฎ๐๐ฟ๐ถ๐ฐ ๐ฝ๐๐๐ฐ๐ต?…
Source: www.youtube.comCategories: General Medicine News, Hem/OncsTweet-
RT @HealthCommunic2: Register for the 1st Webinar from the Asian Region of @IACAPAP on Paediatric psycho-oncology https://t.co/KfYFMNMBEK Cโฆ
-
-
Mashup Score: 1Frequently asked questions on surrogate endpoints in oncology via Bishal Gyawali et al. - OncoDaily - 2 month(s) ago
Frequently asked questions on surrogate endpoints in oncology via Bishal Gyawali et al. / Abhenilย Mittal, Ash Paul, Bishal Gyawali, cancer, Kristin Wright,
Source: oncodaily.comCategories: General Medicine News, Hem/OncsTweet-
RT @oncodaily: Frequently asked questions on surrogate endpoints in oncology via @oncology_bg et al. @pash22 https://t.co/6fxNAwQNke #Caโฆ
-
-
Mashup Score: 17Inequality, Innovation and Common Sense Oncology - 2 month(s) ago
[Oncoinfo โ Istantanee di Oncologia: seguici su http://oncoinfo.it] Is there any real progress today in the globalization of access to oncological care, and …
Source: www.youtube.comCategories: General Medicine News, Hem/OncsTweet-
I had the pleasure of speaking with @Oncoinfo_it during #ESMO24 about @csoncol and our CSO Symposium in Vall dโHebron Hospital, Barcelona. https://t.co/aDmTGiySBg @lucianodf
-
-
Mashup Score: 129Understanding Over-Treatment โ Lessons from a Clinical Trial - 2 month(s) ago
In this Patient Platform, Beth Ciavaglia shares her experience in a randomized, open-label trial of a single one-time dose of zoledronate compared with the standard 6-monthly dose of zoledronate.
Source: evidence.nejm.orgCategories: General Medicine News, Hem/OncsTweet-
This is a brilliant and poignant piece highlighting patient perspectives on overtreatment, clinical trials, and quality of life. I hope many patients read this. https://t.co/RW9d5NKJM8
-
-
Mashup Score: 0Frequently asked questions on surrogate endpoints in oncology-opportunities, pitfalls, and the way forward - 2 month(s) ago
Patients with cancer expect prolonged life (overall survival, OS) or better life (quality of life, QOL) from cancer treatments. However, majority of new cancer drugs are now being approved not based on improved OS or QOL, but based on surrogate endpoints such as tumor shrinkage or delayed tumor progression. These surrogate endpoints, including their validity as a proxy for overall survival, differ based on disease settings and lines of treatment but in general, most surrogate measures have weak correlation with outcomes that matter to patients.
Source: www.thelancet.comCategories: General Medicine News, Hem/OncsTweet-
RT @oncology_bg: Everything you wanted to know about surrogate endpoints but were afraid to ask. https://t.co/c0tyzGzHTE @eClinicalMed #Eโฆ
-
A short take-home version of this paper: https://t.co/jvc1EbqMvx https://t.co/fQoaY64ZFx